Skip to main content

Emcure Pharmaceuticals Limited — ≥1% Shareholders

Every non-promoter shareholder owning 1% or more of Emcure Pharmaceuticals Limited, parsed from the latest quarterly Shareholding Pattern filing. Curated holders link to a tracked profile; mystery holders are flagged.

0 curated 12 mystery Quarter: Mar 2026

Institutional intelligence for Emcure Pharmaceuticals Limited

Cross-view mutual fund activity and super-investor shareholding · Mar 2026 SHP.

Holder Type % of company Shares Value (₹ Cr)
Satish R Mehta individual 39.77% 7,53,96,748
Everest Trust (Shares held by Sanjay Rajanikant Mehta with Sonali Sanjay Mehta, as trustees) dii 7.66% 1,45,20,000
Unity Trust (Shares held by Sunil Rajanikant Mehta with Kamini Sunil Mehta, as trustees) dii 7.65% 1,45,08,000
Samit S Mehta individual 7.14% 1,35,37,632
Bhavana Satish Mehta individual 4.70% 89,16,888
BC Investments IV Limited fii 3.87% 73,39,459
Namita Vikas Thapar individual 2.67% 50,71,200
Pushpa Rajnikant Mehta individual 2.05% 38,86,052
Sanjay Rajanikant Mehta individual 1.95% 37,04,028
Nippon Life India Trustee Ltd-A/C Nippon India Multi Cap Fund dii 1.95% 36,94,528
Sunil Rajanikant Mehta individual 1.50% 28,47,012
Aditya Birla Sun Life Trustee Private Limited A/C - Aditya Birla Sun Life Elss Tax Saver Fund dii 1.31% 24,85,851

Shareholding data sourced from NSE/BSE regulatory filings. Not investment advice. See our disclaimer and methodology.